Every report comes from a Lived member, sent anonymously.
Have you had LVAD for Heart Failure?
A left ventricular assist device (LVAD) is a mechanical pump implanted in the chest to help a failing heart. It draws blood from the left ventricle, the heart's main pumping chamber, and pushes it into the aorta, the large artery that carries blood to the body. A cable called the driveline passes through the skin of the abdomen and connects the pump to a small external computer (the controller) and to batteries or a wall power unit. An LVAD is for people with advanced heart failure whose symptoms can no longer be controlled with medicines, pacing devices or other treatments. It is used in two main ways. As a bridge to transplant, it keeps someone well enough to wait for a donor heart. As destination therapy, it is long-term treatment for people who cannot have a transplant. Occasionally the heart recovers enough for the pump to be removed. The goal can change over time as health changes. Candidates have to be sick enough to need a pump but well enough elsewhere in the body to come through major surgery and live with the device. The main alternatives are continuing medical treatment, care focused on comfort (palliative care) or, for those who qualify, a heart transplant without a pump first. Nearly all new LVADs in the US are now the HeartMate 3, a pump whose spinning part is suspended by magnets rather than resting on bearings. It has lower rates of stroke and pump clotting than older models. An earlier device, the HeartWare HVAD, was taken off the market in 2021, although some people still live with one.
Evaluation is extensive because it decides whether an LVAD is likely to help more than it harms. It usually includes an echocardiogram (an ultrasound of the heart), catheter measurements of pressures inside the heart, an exercise test of how well the heart and lungs deliver oxygen, blood tests of kidney and liver function, lung tests, and routine cancer screening and dental care to reduce infection risk later. Many people are already in the hospital for heart failure when this happens. A social worker also assesses practical and emotional readiness: understanding of the device, substance use, mental health, how well past treatment plans have worked and, importantly, who will be the caregiver. Living with an LVAD takes daily equipment care, so programs generally require a committed caregiver for at least the first weeks at home and a backup person. Before surgery, the team teaches the person and caregiver how the equipment works, and many programs offer a chance to meet other people who have a pump. Insurance approval for the surgery, equipment and ongoing medicines is part of the process.
LVAD implantation is open-heart surgery under general anesthesia, so the person is asleep throughout. It typically lasts four to six hours, sometimes longer. In the usual approach the surgeon opens the breastbone, and a heart-lung machine takes over circulation while the pump is attached. Some centers use smaller incisions that avoid splitting the breastbone. The pump is connected to the left ventricle and to the aorta, and the driveline is tunneled under the skin to exit through the upper abdomen. Once the heart-lung machine is switched off, the pump takes over much of the left ventricle's work. Most implants are planned, but some are done urgently in people who are already very ill or on temporary mechanical heart support in intensive care.
Recovery starts in intensive care, often for several days, with a breathing tube at first and drainage tubes in the chest. Total hospital stays commonly run two to three weeks and can be longer. During that time physical therapists rebuild strength, and the person and caregiver learn how to change batteries, respond to alarms, care for the driveline and track daily readings. Some programs ask people who live far away to stay nearby for a few weeks after discharge. At home, life revolves around a few fixed habits. The pump must always be connected to power, so spare batteries and supplies go everywhere. The driveline exit site needs sterile dressing changes, often daily, and the cable should be protected from pulling. Weight, temperature, blood pressure and pump readings are recorded each day. A blood thinner, usually warfarin, is needed for as long as the pump is in place to prevent clots in the device, and it requires frequent blood tests; some programs add aspirin. Avoid starting new medicines or supplements, including ibuprofen, without the LVAD team's approval, because many can raise bleeding risk or change how warfarin works. Because the pump moves blood continuously, a pulse may be hard to feel and standard blood pressure cuffs may not work, which is worth telling any new clinician or emergency responder. Most people can walk, travel, have sex, shower with precautions, and some return to work. Swimming, baths, hot tubs, contact sports and MRI (magnetic resonance imaging) scans are off limits. The breastbone needs several weeks to heal before heavier lifting. Clinic visits are frequent at first, often weekly for the first month, then spacing out to monthly. For a hazard alarm, follow the steps the LVAD team taught, such as checking connections and changing power, then call the team right away. Call 911, then the LVAD team, if the person faints or becomes unresponsive, the pump stops and does not restart, or there is heavy bleeding, such as vomiting blood or passing large amounts of blood in the stool. Sudden weakness or numbness on one side, trouble speaking, sudden vision loss or a sudden severe headache can mean a stroke: call 911 right away. Call the team promptly for other alarms you cannot resolve, and for signs that point to specific problems: fever or any change at the driveline exit site (infection); black or tarry stools, or unusual bleeding or bruising (bleeding); dark tea- or cola-colored urine (blood-cell damage or a clot in the pump); and sudden weight gain or new swelling (fluid buildup from worsening heart failure).
An LVAD trades the dangers of end-stage heart failure for a different set of risks. The surgery itself carries risks of bleeding, blood clots, breathing problems, heart attack, infection and, in very ill people, death. Over the longer term, the main concerns are bleeding (often in the digestive tract, made more likely by blood thinners), stroke, infection that travels along the driveline, clots or malfunction in the pump, and failure of the right side of the heart, which the device does not support. Irregular heart rhythms and damage to blood cells by the pump can also occur. These problems are common enough to matter. In the large US registry of people with the current pump, about 13% had a stroke and roughly a quarter had digestive tract bleeding within five years, and close to 4 in 10 developed a device-related infection. Many of these events are treatable. Careful driveline care lowers infection risk, and keeping warfarin in its target range balances the risk of clots and stroke against the risk of bleeding. Outcomes have improved substantially. With the current pump, about 86% of people are alive one year after implant and about 60% at five years, with survival in people 65 and older close to half at five years. Most people report less breathlessness and fatigue and more strength than before the pump. Individual outlook depends on how ill someone is at the time of surgery, other health conditions and the goal of therapy.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with LVAD, what to expect, or ask the community a question.